Aspirin for Secondary Prevention of Atherosclerosis
Decades of recommendations to give aspirin for primary prevention of cardiovascular events, based on overoptimistic interpretation of inconclusive data, were recently overturned after a randomized clinical trial with approximately 100 000 person-years of follow-up found that aspirin increased…